Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06306456
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-02-29
Brief Title:
A Phase IbII Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
Sponsor:
Suzhou Genhouse Bio Co Ltd
Organization:
Suzhou Genhouse Bio Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-29
First Submit QC Date:
March 5 2024
Study First Post Date:
2024-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-04
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL